Human monoclonal antibody to lymphadenopathy associated virus

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/140, 167/37,

C12N 5/28 (2006.01) A61K 39/42 (2006.01) C07K 1/22 (2006.01) C07K 16/10 (2006.01) C12N 5/10 (2006.01) C12N 5/24 (2006.01) G01N 33/569 (2006.01) A61K 38/00 (2006.01)

Patent

CA 1339830

Human monoclonal antibodies capable of specifically reacting with an antigenic determinant of LAV/HTLV-III and cell lines producing those monoclonal antibodies are disclosed. The human monoclonal antibodies may be utilized in a method for determining the presence of LAV/HTLV-III in biological samples, or in a method for separating specific antigenic determinants of LAV/HTLV-III from a mixture. Pharmaceutical compositions containing such a human monoclonal antibody, and a method for significantly reducing the infectivity of LAV/HTLV-III in animals using the composition are also disclosed.

540255

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Human monoclonal antibody to lymphadenopathy associated virus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human monoclonal antibody to lymphadenopathy associated virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human monoclonal antibody to lymphadenopathy associated virus will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1267149

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.